News & Analysis as of

Health Care Providers Canada

Smart & Biggar

Health Canada must redetermine exemption requests for psilocybin (magic mushroom)-assisted psychotherapy training

Smart & Biggar on

TheraPsil, a patient advocacy organization, and 73 healthcare practitioners (HCPs) have succeeded in the Federal Court of Appeal (FCA) to overturn the refusal of the Minister of Mental Health and Addictions and Associate...more

Stikeman Elliott LLP

Ontario’s More Convenient Care Act, 2025: A New Strategy for the Healthcare Sector

Stikeman Elliott LLP on

On May 5, 2025, the Ontario government introduced Bill 11, the proposed More Convenient Care Act, 2025 (“MCCA”), a legislative initiative aimed at supporting the province’s long-term healthcare goals for first reading. Bill...more

Smart & Biggar

Minister of Health announces new bilateral agreements with provinces for rare disease drugs

Smart & Biggar on

We previously reported on Canada’s first-ever National Strategy for Drugs for Rare Diseases, which included up to $1.4 billion in funding for provinces and territories, to be negotiated through bilateral agreements. This...more

Stikeman Elliott LLP

Federal Government Announces Policy on Canada Health Act Status of Payments to Regulated Healthcare Professionals Providing...

Stikeman Elliott LLP on

Friday, the Federal Government issued correspondence to the provinces and territories regarding its newly introduced Canada Health Act Services Policy. As set out in this correspondence from the Minister of Health, the CHA...more

Bennett Jones LLP

Supreme Court of Canada Endorses Comity in Class Proceedings in Response to the Opioid Epidemic

Bennett Jones LLP on

A national class action on behalf of multiple Canadian governments to recover opioid epidemic healthcare costs simplifies the aggregation, prosecution, and determination of claims that span geographic boundaries. That is what...more

Stikeman Elliott LLP

Five Takeaways for Health and Social Service Providers Operating in Québec: the Act Respecting Health and Social Services...

Stikeman Elliott LLP on

On July 1, 2024, most of the provisions of Québec’s Bill 3, An Act respecting health and social services and amending various legislative provisions took effect. Now known as the Act respecting health and social services...more

Blake, Cassels & Graydon LLP

Québec : Une loi exhaustive sur la protection des renseignements de santé entre en vigueur

Le 1er juillet 2024, la plupart des dispositions de la loi québécoise intitulée Loi sur les renseignements de santé et de services sociaux et modifiant diverses dispositions législatives (la « Loi ») sont entrées en vigueur,...more

Blake, Cassels & Graydon LLP

Quebec’s Comprehensive Health Information Privacy Law Comes Into Force

On July 1, 2024, most of the provisions of Quebec’s Act respecting health and social services information and amending various legislative provisions (Act) entered into force, along with two related regulations. The Act...more

Smart & Biggar

PMPRB publishes scoping paper for consultation on guidelines, and invites stakeholder feedback

Smart & Biggar on

As we have previously reported, the Patented Medicine Prices Review Board (PMPRB) announced that it will launch the first phase of consultations on new guidelines. On November 10, 2023, the PMPRB published its Scoping Paper...more

Blake, Cassels & Graydon LLP

Ontario Issues Draft Regulation Under New Proposed Health Facilities Regime

On June 9, 2023, the Ontario government published a draft regulation (Draft Regulation) to operationalize the Integrated Community Health Services Centres Act, 2023 (ICHSCA). The ICHSCA was introduced through Bill 60 as part...more

Stikeman Elliott LLP

Alberta Court Establishes New Tort of Harassment

Stikeman Elliott LLP on

In the decision of Alberta Health Services v Johnston, 2023 ABKB 209 (“AHS v Johnston”), an Alberta court established a new tort of harassment. Background Facts - Alberta Health Services (“AHS”) and two named...more

Bennett Jones LLP

The Ontario Court of Appeal Upholds the Use of “Powerful” Epidemiological Data to Infer Causation in the Absence of Scientific...

Bennett Jones LLP on

The Court of Appeal for Ontario in Levac v James, 2023 ONCA 73 [Levac] has unanimously upheld a trial judgment in a common issues trial regarding an infectious disease outbreak in respect of which the allegedly negligent...more

Bennett Jones LLP

Investing in Commercial-Stage Healthcare Companies in Canada: A Recap of BBHIC 2023

Bennett Jones LLP on

The one-and-only Bloom Burton & Co. Healthcare Investor Conference (BBHIC) took place in Toronto last week. Investors and healthcare companies from around the world gathered to discuss the state of the market, meet one-on-one...more

Littler

Ontario, Canada Makes Changes to COVID-19 Requirements for Long Term Care Homes

Littler on

As of October 14, 2022, Ontario made the following changes to its COVID-19 requirements for long term care (LTC) homes, as set out in its COVID-19 guidance document....more

Latham & Watkins LLP

Health Care & Life Sciences: Drug Pricing Digest - September 2022

Latham & Watkins LLP on

Inflation Reduction Act: Stakeholders and commentators continue to review H.R. 5376, the Inflation Reduction Act of 2022 (the Act), which became law on Aug. 16, 2022. Republican leaders on the House Energy & Commerce and...more

Littler

Ontario, Canada Appeal Court Affirms Finding that Midwives Were Underpaid Due to Gender Discrimination

Littler on

In Ontario (Health) v. Association of Ontario Midwives, the Court of Appeal for Ontario (OCA) was satisfied with the reasonableness of the Human Rights Tribunal of Ontario’s (HRTO) finding that the Ministry of Health (MOH)...more

Smart & Biggar

Update on biosimilars in Canada – June 2022

Smart & Biggar on

We provide a further update on developments regarding biosimilars in Canada (approvals, pending submissions, litigation, regulatory, market access and competition) since our last update in October 2021....more

Morrison & Foerster LLP

Quarterly Cartel Catch-Up: Recent Developments in Criminal Antitrust for Busy Corporate Counsel - Q1 2022

Since the last edition of the QCC, there has been a series of dramatic developments in the criminal antitrust enforcement space in the U.S. from the Department of Justice’s Antitrust Division (Division)....more

Stikeman Elliott LLP

Ontario Divisional Court Overturns Certification of Intrusion Upon Seclusion Claim in Data Breach Class Action

Stikeman Elliott LLP on

In Stewart v. Demme, the Ontario Divisional Court (the “Court”) overturned the certification of an intrusion upon seclusion claim in a data breach class action against a hospital, where a nurse used patient health records to...more

Goodwin

Nova Scotia Announces Shift to Biosimilar Drugs

Goodwin on

On February 4, 2022, Nova Scotia announced that as part of the Nova Scotia biosimilar initiative, Nova Scotians enrolled in Pharmacare programs will have 12 months (until February 3, 2023) to work with their healthcare...more

Stikeman Elliott LLP

“Commercially Reasonable Best Efforts”: B.C. Court Provides Guidance in Context of Purchase and Sale Contract

Stikeman Elliott LLP on

In Sutter Hill Management Corporation v. Mpire Capital Corporation (Sutter), the British Columbia Court of Appeal found that the acquiror of an Abbotsford, B.C. care home had breached the purchase and sale agreement by...more

Littler

British Columbia, Canada Announces Vaccination Requirement for Workers in Long-term Care and Assisted Living Facilities

Littler on

British Columbia recently announced new public health requirements regarding COVID-19 vaccinations for those working at long-term care and seniors’ assisted living facilities.  In the announcement, Dr. Bonnie Henry, British...more

Smart & Biggar

Special Access Program and Emergency Drug Release Program amendments in force

Smart & Biggar on

On September 28, 2020, the Regulations Amending Certain Regulations Made under the Food and Drugs Act (Sale of a New Drug for Emergency Treatment) (Regulations) came into force. Health Canada subsequently published a Notice,...more

King & Spalding

FDA Finalizes Rule and Guidance to Implement Safe Importation Action Plan Aimed at Lowering Prescription Drug Prices

King & Spalding on

On September 24, 2020, FDA announced that it was taking action to help lower prescription drug prices by issuing a final rule and a final guidance aimed at facilitating the safe importation of certain prescription drugs....more

Bennett Jones LLP

Remote Health Solutions in Canada and Israel—Here to Stay

Bennett Jones LLP on

Since COVID-19 hit, almost every aspect of our lives has been touched by the pandemic, including the way health care is provided. Remote health solutions (aka digital health solutions, virtual care, telemedicine or...more

39 Results
 / 
View per page
Page: of 2

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide